Literature DB >> 4035778

Non-invasive cardiac study in diabetic Nigerians using systolic time intervals.

O O Famuyiwa, O J Odia, B O Osotimehin, A D Adenle, A O Falase.   

Abstract

Non-invasive cardiac studies using systolic time intervals were performed on 89 diabetic Nigerians and 45 non-diabetic controls, to investigate possible preclinical abnormality of left ventricular function. There was no significant difference in the pre-ejection period to left ventricular ejection time ratio (PEP/LVET) between the patients and controls: 0.373 +/- 0.011 vs 0.365 +/- 0.013 (P = 0.688). Patients at higher risk for developing significant vascular disease i.e. those with peripheral vascular insufficiency, those in higher socio-economic class and those with disease duration of 10 or more years had the highest mean values of PEP/LVET (0.403, 0.403 and 0.412 respectively). However, these values did not reach a level of significance. There was no correlation between PEP/LVET and age, body mass index, duration of diabetes, total or HDL cholesterol and the HDL to total cholesterol ratio. Because recent reports have related diabetic cardiomyopathy to angiopathic disease in diabetes, these results suggest that Nigerian patients, who like most other black African diabetics show little susceptibility to severe vascular complications of diabetes may enjoy some protection from a preclinical abnormality of left ventricular function as well.

Entities:  

Mesh:

Year:  1985        PMID: 4035778

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  2 in total

1.  "Echocardiography in Nigeria: use, problems, reproducibility and potentials".

Authors:  Okechukwu S Ogah; Ademola T Adebanjo; Adedeji S Otukoya; Tarwanger J Jagusa
Journal:  Cardiovasc Ultrasound       Date:  2006-03-21       Impact factor: 2.062

Review 2.  Heart failure in sub-Saharan Africa: a literature review with emphasis on individuals with diabetes.

Authors:  Andre Pascal Kengne; Anastase Dzudie; Eugene Sobngwi
Journal:  Vasc Health Risk Manag       Date:  2008
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.